UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
August 30, 2022
Accession Number:
Submission Type:
CIK:
0001716947
Company Name:
Ensysce Biosciences, Inc.
File Number:
333-267001